Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-17

Clinical Trial Update: The Discriminative Effects of Tramadol in Humans [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 studies explored the discriminative effects of tramadol in humans for opioid use disorder and stimulant use disorder; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tramadol (tramadol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid Abuse, Opioid Addiction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-17